Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan

Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan

OBJECTIVES Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Serological testing for anti-SARS-CoV-2 nucleocapsid (N) antibodies (Abs) and anti-SARS-CoV-2 spike (S) Abs is performed to detect prior COVID-19 infection. It is still contr...

Full description

Bibliographic Details
Main Authors: Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, Miho Yamaguchi, Shota Uchiyama, Tomohiro Koiwa, Moriyuki Nakama, Masaaki Minegishi, Hideaki Nagai, Shigeto Tohma
Format: Article
Language:English
Published: SAGE Publishing 2022-04-01
Series:Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
Online Access:https://doi.org/10.1177/11795484221075492

Internet

https://doi.org/10.1177/11795484221075492

Similar Items